Advanced Clinical announces that Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.
CMDBioscience, a CT based biotechnology company specializing in computer-aided peptide drug discovery, announced today the completion of a research collaboration aimed at identifying novel peptide antagonists of the dengue virus using the CMDBioscience proprietary computational peptide drug discovery platform.
Crystal Pharmatech focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations. Its core services include: salt/polymorph screening, cocrystal screening, chiral resolution, and solid state NMR.
The French Trade Commission UBIFRANCE in London will showcase five innovative companies from the biotechnology and pharmaceutical sectors at the Genesis Conference, which will be held on 9 December 2010 at the Queen Elizabeth II Conference Centre in central London. These French companies are aiming to establish new professional contacts and explore business opportunities between France and the UK.
IN CELL ART, a biotechnology company involved in macromolecular drug (siRNA or DNA) delivery systems, has announced today that the company has entered into a research collaboration agreement with Merial to evaluate IN CELL ART'S nanocarrier technologies in the context of Merial's vaccines programme.
The Mettler Toledo Safeline AXR X-ray system is now available in China and is designed to achieve very fast start-ups and product changeovers in food and pharmaceuticals production.
Gateway Analytical will be exhibiting its pharmaceutical testing services at booth number 2801 at the FIP Pharmaceutical Sciences 2010 World Congress in Association with the AAPS Annual Meeting and Exposition.
Backed by factors like patent expiration of branded drugs and rising government support, the generic market in Canada is expected to reach CAD 9.4 Billion by 2013.
Brian Loew, CEO of Inspire, will be a featured speaker at the DTC 2010 Fall Conference, "Marketing to the Digital Consumer - A Healthcare Perspective." Princeton, NJ-based Inspire creates safe, moderated online communities, organized by medical condition, for patients to share information and to support each other.
HighPoint Solutions (HighPoint) announced today that Chris Colapietro, Vice President of Strategy & Marketing, will be a panelist at the Next Generation Pharma Sales & Marketing Summit, November 16-17 in Baltimore, Maryland.
Velesco Pharmaceutical Services expands core scientific team with Yuan Chen and quality team with Shirley Smith. Both are pharmaceutical industry veterans and bring further experience and expertise to Velesco.
Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen.
While major developed markets for biopharmaceuticals and life sciences will grow just 3 percent to 6 percent through 2014, emerging markets are expected to grow between 14 percent and 17 percent. One of these especially vital and growing markets in biopharma is China.
At a ceremony at the WHO's headquarters in Geneva, Joseph Jimenez, CEO of Novartis, and Dr Margaret Chan, Director-General of the WHO, signed a Memorandum of Understanding (MoU) to continue their collaboration toward a world free of leprosy.
Zydus Nycomed, the joint venture company of Zydus Cadila and Nycomed, has commissioned its newly expanded API manufacturing facility at Navi Mumbai. The company is expected to start commercial production of APIs by December 2010. To start with, the plant will be manufacturing Pantoprazole, Urapidil and Lornoxicam. By 2011, the company will produce eight additional APIs.
Xcelience, a leader in formulation development and early drug development, has recently announced the inclusion of a Vector TFC-220 Roller Compactor in the GMP Manufacturing area, therefore expanding its already impressive solid oral dosage form development and manufacturing capabilities.
The Indian pharmaceutical industry will grow at double digit owing to a rise in pharmaceutical outsourcing and consolidation of highly fragmented industry, says RNCOS in its latest research report.
Satisfied Users & 
Approved Press Releases
